参考文献/References:
1 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010.中华神经科杂志,2010,43(2):146-153.
2 Yang JP,Liu HJ,Yang H,et al.Therapeutic time window for the neuroprotective effects of NGF when administered after focal cerebral ischemia. Neurol Sci, 2011,32(3):433-441.
3 Longa EZ,Weinstein PR,Carison S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989, 20(1): 84-91.
4 Bederson JB,Pitts LH,Tsuji M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke,1986, 17(3):472-476.
5 Solev IN,Balabanyan VY,Volchek IA,et al.Involvement of BDNF and NGF in the mechanism of neuroprotective effect of human recombinant erythropoietin nanoforms. Bull Exp Biol Med, 2013,155(2):242-244.
6 Autry AE, Monteggia LM.Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev,2012,64(2): 238-258.
7 刘 明,刘 洋,张 易,等.梓醇上调NGF、BDNF及mRNA表达伴随缺血性脑卒中大鼠神经功能恢复.中华中医药杂志, 2011,26(5):977-981.